Concepts (145)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arsenic Poisoning | 4 | 2014 | 104 | 0.410 |
Why?
|
| Arsenic | 5 | 2014 | 272 | 0.410 |
Why?
|
| Environmental Exposure | 4 | 2014 | 356 | 0.360 |
Why?
|
| Bangladesh | 9 | 2014 | 339 | 0.300 |
Why?
|
| Drinking Water | 2 | 2013 | 70 | 0.240 |
Why?
|
| Carcinoma | 3 | 2012 | 444 | 0.210 |
Why?
|
| Pancreatic Neoplasms | 3 | 2015 | 725 | 0.210 |
Why?
|
| Food Contamination | 1 | 2013 | 35 | 0.200 |
Why?
|
| Respiration Disorders | 1 | 2013 | 42 | 0.200 |
Why?
|
| Oryza | 1 | 2013 | 45 | 0.200 |
Why?
|
| Smoking | 2 | 2014 | 649 | 0.190 |
Why?
|
| Water Pollutants, Chemical | 1 | 2013 | 140 | 0.180 |
Why?
|
| Biliary Tract Neoplasms | 2 | 2012 | 37 | 0.180 |
Why?
|
| Genome-Wide Association Study | 4 | 2014 | 1766 | 0.170 |
Why?
|
| Colorectal Neoplasms | 3 | 2014 | 1069 | 0.160 |
Why?
|
| Spectrum Analysis | 3 | 2015 | 121 | 0.150 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2014 | 2495 | 0.150 |
Why?
|
| Skin Diseases | 2 | 2013 | 175 | 0.130 |
Why?
|
| Lung | 1 | 2013 | 1380 | 0.130 |
Why?
|
| Duodenoscopy | 1 | 2015 | 9 | 0.120 |
Why?
|
| Fiber Optic Technology | 1 | 2015 | 36 | 0.110 |
Why?
|
| Duodenum | 1 | 2015 | 112 | 0.110 |
Why?
|
| Phosphofructokinase-1, Muscle Type | 1 | 2014 | 9 | 0.110 |
Why?
|
| Environmental Pollutants | 1 | 2014 | 56 | 0.100 |
Why?
|
| Telomere | 1 | 2014 | 121 | 0.100 |
Why?
|
| Arsenicals | 1 | 2013 | 49 | 0.100 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2013 | 50 | 0.100 |
Why?
|
| Scattering, Radiation | 1 | 2013 | 122 | 0.100 |
Why?
|
| Tomography, Optical Coherence | 1 | 2014 | 131 | 0.100 |
Why?
|
| Gene-Environment Interaction | 1 | 2013 | 120 | 0.090 |
Why?
|
| Methyltransferases | 1 | 2013 | 213 | 0.090 |
Why?
|
| Gene Regulatory Networks | 1 | 2014 | 322 | 0.090 |
Why?
|
| Lung Diseases | 1 | 2014 | 288 | 0.090 |
Why?
|
| Middle Aged | 10 | 2015 | 28206 | 0.090 |
Why?
|
| Carcinogenesis | 1 | 2013 | 235 | 0.090 |
Why?
|
| Biopsy | 2 | 2013 | 1208 | 0.080 |
Why?
|
| Body Mass Index | 1 | 2014 | 815 | 0.080 |
Why?
|
| Quantitative Trait Loci | 1 | 2014 | 632 | 0.080 |
Why?
|
| Intestinal Mucosa | 1 | 2015 | 825 | 0.080 |
Why?
|
| Adult | 9 | 2015 | 28578 | 0.080 |
Why?
|
| Epigenesis, Genetic | 1 | 2014 | 555 | 0.080 |
Why?
|
| Colonic Polyps | 1 | 2011 | 137 | 0.080 |
Why?
|
| DNA Methylation | 1 | 2014 | 703 | 0.080 |
Why?
|
| Gene Expression Regulation | 2 | 2014 | 2061 | 0.080 |
Why?
|
| Colonoscopy | 1 | 2011 | 304 | 0.070 |
Why?
|
| Adenoma | 1 | 2011 | 260 | 0.070 |
Why?
|
| Adenocarcinoma | 1 | 2015 | 1192 | 0.070 |
Why?
|
| Female | 12 | 2015 | 49868 | 0.070 |
Why?
|
| Colon | 1 | 2011 | 542 | 0.070 |
Why?
|
| Odds Ratio | 2 | 2013 | 713 | 0.070 |
Why?
|
| Humans | 18 | 2015 | 95798 | 0.070 |
Why?
|
| Adolescent | 5 | 2014 | 9873 | 0.070 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 1319 | 0.070 |
Why?
|
| Young Adult | 4 | 2014 | 7026 | 0.070 |
Why?
|
| Male | 10 | 2015 | 45685 | 0.060 |
Why?
|
| Biomarkers, Tumor | 1 | 2014 | 1670 | 0.060 |
Why?
|
| Chondromatosis | 1 | 1993 | 2 | 0.050 |
Why?
|
| Leiomyoma, Epithelioid | 1 | 1993 | 2 | 0.050 |
Why?
|
| Paraganglioma, Extra-Adrenal | 1 | 1993 | 11 | 0.050 |
Why?
|
| Areca | 1 | 2013 | 11 | 0.050 |
Why?
|
| Mediastinal Neoplasms | 1 | 1993 | 44 | 0.050 |
Why?
|
| Respiratory Function Tests | 1 | 2013 | 157 | 0.050 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 1993 | 101 | 0.050 |
Why?
|
| Aged | 5 | 2015 | 20848 | 0.050 |
Why?
|
| Endoscopy, Digestive System | 2 | 2012 | 72 | 0.040 |
Why?
|
| Smoking Cessation | 1 | 2014 | 272 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2014 | 4664 | 0.040 |
Why?
|
| Stomach Neoplasms | 1 | 1993 | 310 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2015 | 1957 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2014 | 3155 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2013 | 1176 | 0.040 |
Why?
|
| Computer Simulation | 2 | 2014 | 1158 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 1965 | 0.040 |
Why?
|
| Prevalence | 1 | 2013 | 1349 | 0.040 |
Why?
|
| Genotype | 2 | 2014 | 1880 | 0.040 |
Why?
|
| Incidence | 1 | 2013 | 1714 | 0.040 |
Why?
|
| Predictive Value of Tests | 2 | 2015 | 1805 | 0.040 |
Why?
|
| Neoplasm Staging | 2 | 2015 | 2042 | 0.040 |
Why?
|
| Appendicitis | 1 | 1988 | 66 | 0.030 |
Why?
|
| Gene Expression Profiling | 2 | 2014 | 1535 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2014 | 3106 | 0.030 |
Why?
|
| Duodenoscopes | 1 | 2015 | 9 | 0.030 |
Why?
|
| Vitamin E | 1 | 2014 | 34 | 0.030 |
Why?
|
| Asia | 1 | 2014 | 105 | 0.030 |
Why?
|
| Selenium | 1 | 2014 | 46 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2014 | 2474 | 0.030 |
Why?
|
| Chemoprevention | 1 | 2014 | 93 | 0.030 |
Why?
|
| Equipment Design | 1 | 2015 | 427 | 0.030 |
Why?
|
| Risk Factors | 2 | 2015 | 5961 | 0.030 |
Why?
|
| CpG Islands | 1 | 2014 | 169 | 0.030 |
Why?
|
| Cacodylic Acid | 1 | 2013 | 22 | 0.030 |
Why?
|
| Causality | 1 | 2013 | 84 | 0.030 |
Why?
|
| Leukocytes | 1 | 2014 | 213 | 0.030 |
Why?
|
| Monte Carlo Method | 1 | 2013 | 191 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2015 | 816 | 0.020 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2013 | 205 | 0.020 |
Why?
|
| Jaundice, Obstructive | 1 | 2012 | 11 | 0.020 |
Why?
|
| Bile Ducts, Extrahepatic | 1 | 2012 | 12 | 0.020 |
Why?
|
| Light | 1 | 2013 | 297 | 0.020 |
Why?
|
| Ampulla of Vater | 1 | 2012 | 25 | 0.020 |
Why?
|
| Gallbladder | 1 | 2012 | 33 | 0.020 |
Why?
|
| Electroporation | 1 | 2012 | 57 | 0.020 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2012 | 68 | 0.020 |
Why?
|
| Radiology, Interventional | 1 | 2012 | 66 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 900 | 0.020 |
Why?
|
| Ablation Techniques | 1 | 2012 | 41 | 0.020 |
Why?
|
| Ultrasonography, Interventional | 1 | 2012 | 125 | 0.020 |
Why?
|
| Optical Phenomena | 1 | 2011 | 8 | 0.020 |
Why?
|
| Colonoscopes | 1 | 2011 | 13 | 0.020 |
Why?
|
| Photochemotherapy | 1 | 2012 | 101 | 0.020 |
Why?
|
| Drainage | 1 | 2012 | 172 | 0.020 |
Why?
|
| Brachytherapy | 1 | 2012 | 127 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 1993 | 2386 | 0.020 |
Why?
|
| Fluorescence | 1 | 2011 | 103 | 0.020 |
Why?
|
| Alleles | 1 | 2014 | 1157 | 0.020 |
Why?
|
| Skin | 1 | 2014 | 604 | 0.020 |
Why?
|
| Radiopharmaceuticals | 1 | 2012 | 204 | 0.020 |
Why?
|
| Chromosome Aberrations | 1 | 2012 | 353 | 0.020 |
Why?
|
| Lymph Node Excision | 1 | 2012 | 234 | 0.020 |
Why?
|
| Radiotherapy | 1 | 2012 | 325 | 0.020 |
Why?
|
| Video Recording | 1 | 2011 | 215 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2012 | 417 | 0.020 |
Why?
|
| Skin Neoplasms | 1 | 2014 | 621 | 0.020 |
Why?
|
| Embolization, Therapeutic | 1 | 2012 | 279 | 0.020 |
Why?
|
| Stents | 1 | 2012 | 422 | 0.020 |
Why?
|
| DNA | 1 | 2014 | 1327 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2012 | 1739 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2012 | 475 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2014 | 1422 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2012 | 1079 | 0.020 |
Why?
|
| Phenotype | 1 | 2014 | 2575 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2015 | 2480 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2012 | 591 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2011 | 1613 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2011 | 2039 | 0.020 |
Why?
|
| Liver Transplantation | 1 | 2012 | 1201 | 0.010 |
Why?
|
| Syndrome | 1 | 1993 | 450 | 0.010 |
Why?
|
| Mutation | 1 | 2012 | 4374 | 0.010 |
Why?
|
| Child | 2 | 1993 | 7618 | 0.010 |
Why?
|
| False Negative Reactions | 1 | 1988 | 61 | 0.010 |
Why?
|
| False Positive Reactions | 1 | 1988 | 220 | 0.010 |
Why?
|
| Acute Disease | 1 | 1988 | 859 | 0.010 |
Why?
|
| Ultrasonography | 1 | 1988 | 747 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1988 | 3970 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 1988 | 10273 | 0.000 |
Why?
|